Detta är den viktigaste artikel som poppat upp hittills i tråden denna månad
(Ursprungligen postat av wedonthavetime)
https://www.medrxiv.org/content/10.1101/2020.02.18.20024539v2.full.pdf
Gaohong Sheng et al. [22] have shown that viral infection could increase the risk of pulmonary fibrosis. Xie et al. [23]
found that 45% of patients showed signs of pulmonary fibrosis within one month after being infected with SARS-CoV. Hui et al. [24] revealed that 36% and 30% of patients infected with SARS-CoV developed pulmonary fibrosis 3 and 6 months after infection. These studies consistently suggest that pulmonary fibrosis will become one of the serious complications in patients with 2019-nCoV infection. How to prevent and reduce the occurrence of pulmonary fibrosis in patients with 2019-nCoV infection are urgent problems for medical workers in the treatment of 2019-nCoV.
[22] Sheng G, Chen P, Wei Y, et al. Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis.
Chest 2019. doi: 10.1016/j.chest.2019.10.032. [23] Xie L, Liu Y, Xiao Y, et al. Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge.
Chest 2005. 127(6):2119-24.
[24] Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function,
functional capacity and quality of life in a cohort of survivors.
Thorax 2005. 60(5):401-9.
------
Each month, the journal CHEST® features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine:
------
Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice. This includes articles concerning basic and translational mechanisms with application to clinical material (cell and molecular biology, genetics, epidemiology, and immunology).
Thorax is an official journal of the British Thoracic Society.